Summary
24 / 100 · Bulios Score
What speaks for it
- It has raised its dividend 33 years in a row.
- The share price is below the Bulios Fair Price.
What to watch
- The company made a loss over the last 12 months.
- Earnings per share fell by 36% a year over the last 3 years.
- Repaying its net debt would take 7.8 years of operating profit.
- It missed profit estimates 5 times in the last 6 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
There is not enough revenue history yet to say how fast it grows. Earnings per share fell by 36% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $2.46M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 50.5 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 8.04%
- Raised in a row
- 33 years
You receive $3.30 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2026By product
- Tobacco Sales 82%
- Food Ingredient Sales 11%
- Product and Service, Other 4.1%
- Service, Other 2.6%
By region
- All Other Countries 28%
- UNITED STATES 23%
- BELGIUM 19%
- INDONESIA 6.6%
- POLAND 5.8%
- Other 18%
Tobacco Sales brings in 82% of revenue. Product and Service, Other grew fastest, by 19% a year.
Segments in detail